Weekly Research Analysts’ Ratings Updates for Sabra Healthcare REIT (SBRA)

Sabra Healthcare REIT (NASDAQ: SBRA) has recently received a number of price target changes and ratings updates:

• 10/19/2026 – Sabra Healthcare REIT had its price target lowered by Wells Fargo & Company from $23.00 to $21.00. They now have an “overweight” rating on the stock.
• 10/13/2026 – Sabra Healthcare REIT had its price target lowered by UBS Group from $21.00 to $20.00. They now have a “neutral” rating on the stock.
• 10/13/2026 – Sabra Healthcare REIT had its price target lowered by Barclays from $23.00 to $21.00. They now have an “equal weight” rating on the stock.
• 10/8/2026 – Sabra Healthcare REIT was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”.
• 9/10/2026 – Sabra Healthcare REIT is now covered by Huntington. They set an “outperform” rating and a $23.00 price target on the stock.
• 8/31/2026 – Sabra Healthcare REIT was given a new $21.00 price target by Mizuho.
• 8/31/2026 – Sabra Healthcare REIT had its price target raised by Barclays from $21.00 to $23.00. They now have an “equal weight” rating on the stock.
• 8/31/2026 – Sabra Healthcare REIT had its price target raised by Robert W. Baird from $20.00 to $21.00. They now have a “neutral” rating on the stock.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.1%. The ex-dividend date of this dividend was Friday, August 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 461.54%.

Insiders Place Their Bets

In related news, CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the sale, the chief executive officer owned 1,657,686 shares in the company, valued at $34,529,599.38. This trade represents a 10.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by insiders.

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.